CEO and Co-Founder at DZZOM, a spin-off company of Northeastern University’s Network Science Institute. DZZOM is a Boston-based start-up company commercializing the field of Network Medicine to uncover actionable molecular pathways that define and regulate human disease.
Mr. Veidner has 12 years of experience in biotech management and strategic consulting in Switzerland, Germany and Central Europe. Beforehand, he was director at PCA Capital Advisors (Frankfurt), a biotech focused corporate finance boutique. He graduated at the Master in Biotechnology Management program of IE Business School (Madrid/Spain).